ETFB Human

Electron-Transfer-Flavoprotein Beta Polypeptide Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure

ETFB Human is a 275-amino acid protein with a molecular mass of 30.0 kDa. The recombinant variant (PRO-220) includes an N-terminal His-tag and is expressed in E. coli . Key structural features include:

  • Domains: Three distinct regions (I, II, III) with FAD bound between ETF-α and ETF-β subunits and AMP buried in domain III .

PropertyDetails
Purity>90% (SDS-PAGE)
Storage4°C (short-term), -20°C (long-term)
Buffer Composition20 mM Tris-HCl (pH 8.0), 40% glycerol

Functional Role

ETF acts as an electron carrier in mitochondrial metabolism:

  • Electron Transfer: Accepts electrons from 14+ flavoenzymes (e.g., acyl-CoA dehydrogenases, glutaryl-CoA dehydrogenase) and transfers them to ETF:ubiquinone oxidoreductase (ETFDH), feeding into the respiratory chain .

  • Metabolic Pathways:

    • Fatty acid β-oxidation

    • Amino acid catabolism (e.g., leucine, lysine)

    • Choline metabolism

Key Interaction Partners:

ProteinFunctionInteraction Score
ETFDHETF-ubiquinone oxidoreductase; relays electrons to CoQ100.999
ETFAETF-α subunit; stabilizes FAD binding0.999
ACADMMedium-chain acyl-CoA dehydrogenase; initiates fatty acid β-oxidation0.991

Clinical Significance

Mutations in ETFB cause multiple acyl-CoA dehydrogenase deficiency (MADD), an autosomal recessive disorder :

  • Symptoms: Hypoglycemia, metabolic acidosis, organic aciduria (elevated glutaric, ethylmalonic acids).

  • Diagnostic Markers:

    • Urinary excretion of dicarboxylic acids

    • Reduced ETF activity in fibroblasts

Reported Pathogenic Mutations:

MutationEffectReference
R191CDisrupts FAD binding
Y207DImpairs electron transfer to ETFDH

Research Applications

Recombinant ETFB Human (PRO-220) is widely used for:

  • Enzyme Activity Assays: Measuring ETF-dependent dehydrogenase interactions .

  • Structural Studies: Investigating conformational changes during electron transfer .

  • Disease Modeling: Studying MADD pathogenesis and screening therapeutic compounds .

Pharmacological Status

As of 2025, no approved drugs target ETFB directly. Research focuses on:

  • Small molecule chaperones to stabilize mutant ETF proteins .

  • Gene therapy approaches for ETFB-related MADD .

Product Specs

Introduction
Electron transfer flavoprotein subunit beta (ETFB) forms a heterodimer with the alpha subunit to create ETF. ETF is involved in the transport of electrons between primary flavoprotein dehydrogenases, which are involved in mitochondrial fatty acid and amino acid catabolism, and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase.
Description
Recombinant human ETFB protein is produced in E. coli. A 20 amino acid His tag is fused to the N-terminus. This results in a single, non-glycosylated polypeptide chain containing 275 amino acids (residues 1-255 of the ETFB protein and a 20 amino acid His tag). The molecular weight of the protein is 30.0 kDa. ETFB is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The ETFB solution has a concentration of 0.25 mg/ml and is supplied in 20 mM Tris-HCl buffer (pH 8.0) containing 40% glycerol and 0.1 M NaCl.
Stability
For short-term storage (2-4 weeks), the ETFB solution should be stored at 4°C. For long-term storage, it is recommended to store the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of ETFB is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
Electron-transfer-flavoprotein beta polypeptide, MADD, beta-ETF.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAELRVLVAV KRVIDYAVKI RVKPDRTGVV TDGVKHSMNP FCEIAVEEAV RLKEKKLVKE VIAVSCGPAQ CQETIRTALA MGADRGIHVE VPPAEAERLG PLQVARVLAK LAEKEKVDLV LLGKQAIDDD CNQTGQMTAG FLDWPQGTFA SQVTLEGDKL
KVEREIDGGL ETLRLKLPAV VTADLRLNEP RYATLPNIMK AKKKKIEVIK PGDLGVDLTS KLSVISVEDP PQRTAGVKVE TTEDLVAKLK EIGRI.

Product Science Overview

Structure and Function

ETFB is a heterodimeric protein composed of an alpha and beta subunit. The beta subunit, which is the focus here, contains an FAD (flavin adenine dinucleotide) cofactor and an AMP (adenosine monophosphate) molecule. These molecules are crucial for the protein’s function in electron transfer . The ETF complex accepts electrons from various mitochondrial dehydrogenases, including acyl-CoA dehydrogenases, and transfers them to the main mitochondrial respiratory chain via ETF-ubiquinone oxidoreductase .

Role in Metabolism

ETFB is involved in the metabolism of fatty acids and amino acids. It shuttles electrons between primary flavoprotein dehydrogenases and the membrane-bound electron transfer flavoprotein ubiquinone oxidoreductase. This process is vital for normal mitochondrial fatty acid oxidation and amino acid metabolism . Deficiencies in ETFB can lead to metabolic disorders such as Multiple Acyl-CoA Dehydrogenase Deficiency (MADD), also known as glutaric acidemia type II .

Human Recombinant ETFB

Recombinant ETFB is produced using recombinant DNA technology, which involves inserting the ETFB gene into a suitable expression system, such as E. coli, to produce the protein in large quantities. The recombinant protein is then purified using chromatographic techniques . This recombinant form is used in research to study the protein’s structure, function, and role in metabolic diseases.

Clinical Significance

Mutations in the ETFB gene can lead to severe metabolic disorders. For instance, MADD is characterized by the accumulation of organic acids and fatty acid metabolites in the body, leading to symptoms such as muscle weakness, hypoglycemia, and metabolic acidosis . Understanding the structure and function of ETFB is crucial for developing therapeutic strategies for these conditions.

Research and Applications

Research on ETFB has provided insights into its role in mitochondrial function and its involvement in metabolic diseases. Studies have shown that ETFB binds an AMP molecule that likely has a structural role . Additionally, the three-dimensional structure of human ETFB has been resolved, providing a detailed understanding of its function at the molecular level .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.